Clinical Trials Browser

Phase 1/2 × Solid Tumors Harboring NTRK Fusion × 90 days × Clear all

NCT07394374 2026-02-06

A Phase 1/2 Study of CG001419 Tablets in Adult Subjects With Locally Advanced or Metastatic Solid Tumours Harbouring NTRK Gene Abnormalities

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors Harboring NTRK Fusion